Kathryn Pepple is an Ophthalmology physician affiliated with University of Washington. OpenAlex indexes 83 publications with 1,446 citations (h-index 22).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
908 Jefferson St
7th Floor
Seattle, WA 981042433
Telephone
206-744-8638Registry record last updated 3 Sept 2013.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Genentech USA, Inc.Program year20254 payments
- Janssen Research & Development, LLCProgram year20253 payments
- F. Hoffmann-La Roche AGProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
31%Corticosteroid18.6%Prednisolone Acetate67%Fluorometholone33%Part D<11 patientsalpha-Adrenergic Agonist6.7%Combigan100%Part D<11 patients+ 1 more class in this area
Cancer & immunology
26.7%Folate Analog Metabolic Inhibitor17.6%Methotrexate100%Part D<11 patientsTNF inhibitor9%Humira(Cf) Pen100%Part D<11 patientsMetabolism & gastrointestinal
13.8%Corticosteroid13.8%Prednisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2014–2023 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Evidence and Consensus Based Imaging Guidelines in Multiple Evanescent White Dot Syndrome Multimodal imaging in Uveitis (MUV) Taskforce Report 6
American Journal of Ophthalmology
2025 - Immunology of Retinitis Pigmentosa and Gene Therapy–Associated Uveitis
Cold Spring Harbor Perspectives in Medicine
2023 - Gender Distribution and Trends of Ophthalmology Subspecialties, 1992-2020
American Journal of Ophthalmology
2023 - Aqueous Macrophages Contribute to Conserved CCL2 and CXCL10 Gradients in Uveitis
Ophthalmology Science
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Neal Futran, MD, DMD
University of Washington
Elizabeth Swisher
University of Washington
David Tirschwell
University of Washington
Elaine Peskind, MD
University of Washington
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”